Mid- to Late-Life Time-Averaged Cumulative Blood Pressure and Late-Life Cardiac Structure, Function, and Heart Failure.

Hypertension
Kanako TeramotoAmil Shah

Abstract

Limited data exist regarding systolic blood pressure (SBP) through mid- to late-life and late-life cardiac function and heart failure (HF) risk. Among 4578 HF-free participants in the ARIC study (Atherosclerosis Risk in Communities) attending the fifth visit (2011-2013; age 75±5 years), time-averaged cumulative SBP was calculated as the sum of averaged SBPs from adjacent consecutive visits (visits 1-5) indexed to total observation time (24±1 years). Calculations were performed using measured SBPs and also incorporating antihypertensive medication specific effect constants (underlying SBP). Outcomes included comprehensive echocardiography at visit 5 and post-visit 5 incident HF, HF with preserved ejection fraction, and reduced ejection fraction. Higher cumulative SBP was associated with greater left ventricular mass and worse diastolic measures (all P<0.001), associations that were stronger with underlying compared with cumulative SBP (all P<0.05). At 5.6±1.2 years follow-up post-visit 5, higher cumulative measured and underlying SBP were associated with incident HF (hazard ratio per 10 mm Hg for measured: 1.12 [1.01-1.24]; underlying: 1.19 [95% CI, 1.10-1.30]) and HF with preserved ejection fraction (measured: 1.15 [1.00-1.33];...Continue Reading

References

Jul 1, 1975·The Journal of Clinical Investigation·W GrossmanL P McLaurin
Jan 5, 2002·Circulation·Ramachandran S VasanUNKNOWN Framingham Heart Study
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Aug 2, 2005·American Journal of Hypertension·Jun WuD C Rao
May 9, 2007·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Partho P SenguptaMarek Belohlavek
Apr 2, 2008·The New England Journal of Medicine·Nigel S BeckettUNKNOWN HYVET Study Group
Dec 10, 2009·Hypertension·Scott D SolomonUNKNOWN Exforge Intensive Control of Hypertension to Evaluate Efficacy in Diastolic Dysfunction Investigators
May 9, 2012·Hypertension·Brent M EganKristina S Yu-Isenberg
Nov 5, 2013·Journal of the American College of Cardiology·Elisabeth Kraigher-KrainerUNKNOWN PARAMOUNT Investigators
Sep 24, 2014·European Heart Journal·Arjun K GhoshUNKNOWN Medical Research Council National Survey of Health and Development (NHSD) Scientific and Data Collection Team
Jun 27, 2015·Journal of the American College of Cardiology·Satoru KishiJoão A C Lima
Aug 12, 2015·Journal of the American Society of Hypertension : JASH·Anthony BonifontePeter W F Wilson
Nov 10, 2015·The New England Journal of Medicine·UNKNOWN SPRINT Research GroupWalter T Ambrosius
May 20, 2016·JAMA : the Journal of the American Medical Association·Jeff D WilliamsonUNKNOWN SPRINT Research Group
Jan 25, 2017·Journal of Hypertension·Andreas SchneiderBernhard M W Schmidt
Oct 26, 2018·Hypertension·Sante D PierdomenicoJan A Staessen
Apr 12, 2019·Nature·Gabriele G SchiattarellaJoseph A Hill

❮ Previous
Next ❯

Citations

Jun 12, 2021·Journal of the American College of Cardiology·Jacqueline D WrightGerardo Heiss
Aug 20, 2021·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Chang Seong KimSoo Wan Kim
Sep 22, 2021·The Journal of Clinical Hypertension·Magnus O WijkmanOrly Vardeny

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.